Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
1
33%
Ph phase_4
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Completed1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

completed133%
terminated133%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients

NCT03151291
completedphase_2

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

NCT00432913
terminatedphase_4

Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels

NCT00578578

Clinical Trials (3)

Showing 3 of 3 trials
NCT03151291Not Applicable

Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients

Unknown
NCT00432913Phase 2

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

Completed
NCT00578578Phase 4

Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3